Searched for
DIAGNOSTIC TEST KITS
Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...- Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPOMolbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...
- In 2009, a Navy veteran's low-cost invention helped thousands get glasses in places without eye doctorsUSee Vision Kit: Retired US Navy and Marine Corps officer, Kevin White, has pioneered a vision testing system aimed at providing affordable...
- Global smart money can't get enough of India's next growth storyGlobal private equity firms are expanding beyond hospitals into India's broader healthcare ecosystem, with Warburg Pincus, TA Associates, B...
- Own a good business: Volatility, Iran, Trump will all be taken care of. 7 large-cap stocks with upside potential of up to 33%There was a time when many investors said with pride that they owned only blue chips. Today, there are probably only a few of them left. An...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- For investors who focus on the long term: 5 mid-cap stocks from different sectors with upside potential up to 28%When prices fall, caution comes naturally. Investors hesitate, portfolios are reviewed less often, and even optimists become careful. But w...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...
- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- TCS deploys blockchain-based system to speed up Covid-19 diagnostic test-kit productionAs a technology partner to C-CAMP, TCS has developed and deployed a digital supply-chain platform to manage the MSME ecosystem, based on it...
- GenePath Diagnostics develops quantitative COVID-19 test kit for drug makersThe kit is currently being used by a couple of unidentified drug makers in India, said GenePath Diagnostics CEO Nickhil Jakatdar. He said t...
- Covid-19 test kit Corosure developed by IIT Delhi launched; base price at Rs 399With the launch, the RT-PCR based Covid-19 diagnostic kit will now be available for use by the authorised testing labs. Even after adding t...
- Govt restricts export of swabs, probes, primers specific for Covid-19 testingIt also retained the restrictions on the export of specific diagnostic kits, reagents, and instruments such as swabs sterile synthetic fibr...
- COVID-19 impact: Test-kit makers rue ‘total’ export banMolecular diagnostics companies have expressed concern after the government on Saturday decided to ban export of all diagnostic kits and re...
- 14 firms get license to evaluate COVID-19 tests kitsRoche Diagnostics India and other 13 Indian firms include CoSara Diagnostics from Ahmedabad and CPC Diagnostics from Chennai. All these com...
- Budget 2012: Exempt duty for antigens/antibodies used in diagnostic kits, says FICCIThe import of raw materials such as antigens/antibodies or any other ingredient corresponding to the manufacture of diagnostic test kits sp...
- Global pharma cos to ramp up test kit productionUS-based Applied Biosystems and Swiss major Roche Diagnostics, two of the world’s largest swine flu kit makers, have decided to ramp up the...
Load More
